Immunotherapy and stem cell technology represent two of the hottest fields in medical science today. Although there is still much research to be done, immunotherapy is seen as the ultimate weapon against some of the most intractable diseases, essentially having the best potential to hunt out and destroy bad cells. And stem cell technology is seen as the best hope for regenerating the body, essentially building more good cells.
But there’s a third less known but no less important component to the future of modern medicine. It’s called pharmacogenomics, a field of study derived from the Human Genome Project. The goal of pharmacogenomics is to provide doctors and researchers the tools necessary to accurately assess genetic variations in patients, and eventually provide drug treatment options that are finely tuned to each patient’s needs, avoiding the trial-and-error approach that doctors are so often forced to rely on. It’s a critical science that could greatly leverage other medical technologies.
Differences in how drugs are metabolized, and their ultimate effects, frequently have a genetic base, and knowing a patient’s genetic makeup could mean the difference between a treatment’s success and failure. When Rainbow Coral Corp. recently announced its plan to partner with a genome-mapping facility in Houston, they were targeting one of the fastest growing segments in biotech, the genetic testing sector, expected to reach $2.2 billion by 2017.
It’s just one of the company’s moves to implement its strategy of developing the best research and drug therapy products. Rainbow also recently acquired a new equity interest in Nano3D Biosciences, an emerging biotech game-changer, whose Bio-Assembler technology may soon allow researchers to dramatically shorten the development timeline for new drugs and treatments, an area that has the potential for explosive growth.
For additional information, visit www.RainbowbioSciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment